Hussey is a serial entrepreneur and veteran C-suite executive with more than 35 years in the biotech and pharmaceutical industry
DOWNLOAD PDFChicago, IL – October 13, 2020 — Vodori, creator of cloud-based software that revolutionizes how life science companies get regulated content to market, today announced that James M. Hussey, CEO of Seneca Therapeutics, joins Vodori’s Board of Directors. The appointment of Mr. Hussey increases the size of the Vodori Board of Directors to eight members.
“Jim is a seasoned leader in the life science industry who has been a sounding board and advisor to Vodori’s leadership team for more than a year,” said Scott Rovegno, Vodori Founder and CEO. “Jim has served as CEO at multiple pharmaceutical and biotechnology companies for two decades, providing him with his perspective and expertise to advocate for our customers’ needs and helps us grow our Pepper Cloud® product suite in a way that best meets those needs. We are fiercely committed to developing high-value, high-quality software for our customers, and Jim will ensure that we continue to deliver on that commitment.”
“I am honored to serve on the Vodori Board of Directors,” said James Hussey. “Vodori’s Pepper Flow® software is unlike any other promotional review software in the market due to its ease of use and industry focus. I believe it can provide meaningful benefits to life science companies that are under more pressure than ever to move fast and deliver therapeutic products while meeting required guidelines.”
Hussey is currently CEO and member of the Board of Directors of Seneca Therapeutics, a clinical stage biopharmaceutical company dedicated to the development of oncolytic immune therapeutics based on Seneca Valley Virus (SVV-001). Jim has been a CEO or President for nearly 20 years, has been a member of the C-Suite at several successful biotech/pharmaceutical companies and has deep experience in leading and growing technology start-up companies.
In his 35+ year career in pharmaceutical and biotech companies, Hussey has served in roles ranging from CEO of Nanolink, NeoPharm and Physicians Quality Care, to President at Sagent Pharmaceuticals, Executive Vice President at Athenex, and General Manager at Bristol-Myers Squibb.
Learn more at www.vodori.com.
About Vodori
Vodori is the creator of the Pepper Cloud Product Suite: modern, cloud-based software that revolutionizes how life science companies review, approve, and distribute regulated content. The Pepper Cloud Product Suite, which includes Pepper Flow, Pepper Folio, and Pepper Flow Digital Review, is used by thousands of life science professionals in more than 35 countries worldwide. Vodori is committed to excellence in product usability and providing world-class customer service. For more information, visit vodori.com.
Contact:
Annalise Ludtke
Vodori, Inc.
269.808.0012
annalise.ludtke@vodori.com
Other posts you might be interested in
View All Posts
4 min read
| July 7, 2020
DiaSorin Selects Vodori’s Pepper Flow to Support Rapid Growth and Increased Product Launches | Vodori
Read More
2 min read
| November 5, 2020
Vodori Announces Appointment of Lesly Marban to its Board of Advisors
Read More
3 min read
| May 6, 2020
Vodori raises $3M to Expand its Suite of Next Generation Life Science Software | Vodori
Read MoreSubscribe to Vodori
We'll send you content and resources on MLR best practices, collaboration tips, and more. By subscribing, you consent to allow Vodori to store and process the personal information submitted to receive communications from Vodori. You may unsubscribe at any time. For more information, review our Privacy Policy.